Login / Signup

Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study.

Bin FanGhassan K Abou-AlfaAndrew X ZhuShuchi S PandyaHongxia JiaFeng YinCamelia GliserZhaowei HuaMohammad HossainHua Yang
Published in: Cancer chemotherapy and pharmacology (2024)
NCT02989857 Registered February 20, 2017.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • phase ii
  • low grade
  • placebo controlled
  • study protocol